➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
AstraZeneca
McKesson
Harvard Business School
Moodys

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Bupivacaine - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for bupivacaine and what is the scope of patent protection?

Bupivacaine is the generic ingredient in twelve branded drugs marketed by Pacira Pharms Inc, Aurobindo Pharma Ltd, Hospira, Mylan Asi, Novocol Healthcare, Intl Medicated, Fresenius Kabi Usa, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, Septodont, and Amphastar Pharms Inc, and is included in forty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Bupivacaine has nineteen patent family members in nine countries.

There are twelve drug master file entries for bupivacaine. One supplier is listed for this compound.

Drug Prices for bupivacaine

See drug prices for bupivacaine

Recent Clinical Trials for bupivacaine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
M.D. Anderson Cancer CenterPhase 2
Mayo ClinicPhase 1

See all bupivacaine clinical trials

Pharmacology for bupivacaine
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for bupivacaine
Synonyms for bupivacaine
(.+/-.)-1-Butyl-2',6'-pipecoloxylidide
(.+/-.)-Bupivacaine
(+-)-Bupivacaine
(+/-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(plusmn)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboximidic acid
1-butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
14252-80-3 (HCl)
18010-40-7 (HCl)
180B929
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (.+/-.)-
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-
2',6'-Pipecoloxylidide, 1-butyl-
2180-92-9
38396-39-3
4CH-013994
73360-54-0 (HCl.H2O)
AB00053674
AB00053674_10
AB00053674_11
AB00053674-08
AB00053674-09
AC-2096
AH 250
AK-90074
AKOS001637202
AKOS016842516
Anekain
ANW-45984
API0007792
AX8041457
BCP12242
BCP21825
BDBM50350790
Bloqueina
BPBio1_000298
BRD-A01636364-003-05-2
BRD-A01636364-003-08-6
BS-5224
BSPBio_000270
BSPBio_002607
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (USAN/INN)
Bupivacaine [INN:BAN]
Bupivacaine [USAN:INN:BAN]
bupivacaine base
Bupivacaine Carbonate
Bupivacaine HCL KIT
Bupivacaine liposome injectable suspension
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine,hydrochloride
Bupivacainum
Bupivacainum [INN-Latin]
C07529
C18H28N2O
Carbostesin
cBupivacaine
CHEBI:3215
CHEBI:77431
CHEMBL1098
CS-W023182
CTK8B4736
D07552
DB-119016
DB00297
DivK1c_000758
dl-1-Butyl-2,6-pipecoloxylidide
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DTXSID2022703
DUR-843
EINECS 218-553-3
EINECS 253-911-2
Epitope ID:122662
Exparel
Exparel (TN)
FT-0623286
FT-0699781
GTPL2397
HMS2090F12
HMS3428P06
HSDB 7790
IDI1_000758
J10217
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KS-00000ZRC
L000695
LAC-43
LAC-43 (Salt/Mix)
LEBVLXFERQHONN-UHFFFAOYSA-N
Levobupivacaine free base
LIQ-865
LIQ865
LS-109841
LS-2222
M-9606
Marcaine
Marcaine hydrochloride (Salt/Mix)
Marcaine spinal (Salt/Mix)
MCULE-2286784276
MFCD00941462
N-(2,6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide
NCGC00178579-01
NCGC00178579-02
NINDS_000758
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Q-100271
Q422806
R962
racemic bupivacaine
SBI-0051846.P002
SC-26838
SCHEMBL25438
Sensorcaine
SKY 0402
SKY-0402
SKY0402
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
ST065773
ST2415271
STL484283
TC-134729
Win 11318

US Patents and Regulatory Information for bupivacaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 070586-001 Mar 3, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 070966-001 Oct 13, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE bupivacaine hydrochloride; epinephrine INJECTABLE;INJECTION 071166-001 Jun 16, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 070583-001 Feb 17, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 071810-001 Dec 11, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for bupivacaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011   Start Trial   Start Trial
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011   Start Trial   Start Trial
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011   Start Trial   Start Trial
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011   Start Trial   Start Trial
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
AstraZeneca
McKesson
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.